Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedSep 5, 2018Methyl-Cobalamin injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1162-2018Class IITerminatedSep 5, 2018Methyl-Cobalamin injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1161-2018Class IITerminatedSep 5, 2018Methyl-Cobalamin injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1160-2018Class IITerminatedSep 5, 2018Glutathione injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1159-2018Class IITerminatedSep 5, 2018Dexpanthenol injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1158-2018Class IITerminatedSep 5, 2018Calcium Gluconate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1157-2018Class IITerminatedSep 5, 2018CoEnzyme-Q10 injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1156-2018Class IITerminatedSep 5, 2018Ipamorelin 9 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1155-2018Class IITerminatedSep 5, 2018Methylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1154-2018Class IITerminatedSep 5, 2018Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1153-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1152-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 4000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1151-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1150-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 20000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1149-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 11000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1148-2018Class IITerminatedSep 5, 2018Human Chorionic Gonadotropin 5000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeachLack of assurance of sterility.Pharmcore Inc. · D-1147-2018Class IITerminatedSep 5, 2018Amlodipine/Valsartan/HCTZ 10mg/320mg/25mg TabletCGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.RemedyRepack Inc. · D-1146-2018Class IIOngoingSep 5, 2018AmlodipineCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1145-2018Class IIOngoingSep 5, 2018AmlodipineCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1144-2018Class IIOngoingSep 5, 2018AmlodipineCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1143-2018Class IIOngoingSep 5, 2018AmlodipineCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1142-2018Class IIOngoingSep 5, 2018AmlodipineCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1141-2018Class IIOngoingSep 5, 2018Amlodipine and Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1140-2018Class IIOngoingSep 5, 2018Amlodipine and Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1139-2018Class IIOngoingSep 5, 2018Amlodipine and Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1138-2018Class IIOngoingSep 5, 2018Amlodipine and Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1137-2018Class IIOngoingSep 5, 2018Valsartan Tablets USPCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1136-2018Class IIOngoingSep 5, 2018Valsartan Tablets USPCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1135-2018Class IIOngoingSep 5, 2018Valsartan Tablets USPCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Torrent Pharma Inc. · D-1134-2018Class IITerminatedSep 5, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.AVKARE Inc. · D-1133-2018Class IITerminatedSep 5, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.AVKARE Inc. · D-1132-2018Class IITerminatedSep 5, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.AVKARE Inc. · D-1131-2018Class IITerminatedSep 5, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.AVKARE Inc. · D-1130-2018Class IIITerminatedSep 5, 2018Oxycodone and Acetaminophen TabletsLabeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct...Mayne Pharma Inc · D-1129-2018Class IITerminatedSep 5, 20180.9% Sodium Chloride Injection USP 100 mL bagsCGMP DeviationsBaxter Healthcare Corporation · D-1128-2018Class IITerminatedSep 5, 2018Doxycycline Hyclate USP TabletsFailed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.PD-Rx Pharmaceuticals, Inc. · D-1127-2018Class ITerminatedSep 5, 2018Living Well Remedies Weight Away RemedyMicrobial Contamination of Non-Sterile Products: Weight Away Remedy is being recall due to out of specification microbial results.Living Well Remedies, LLC · D-0004-2019Class ITerminatedAug 29, 2018Levothyroxine and LiothyronineFailed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good...Westminster Pharmaceuticals LLC · D-1182-2018Class ITerminatedAug 29, 2018Levothyroxine and LiothyronineFailed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good...Westminster Pharmaceuticals LLC · D-1181-2018Class ITerminatedAug 29, 2018Levothyroxine and LiothyronineFailed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good...Westminster Pharmaceuticals LLC · D-1180-2018